2015
Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies
Fondell E, O’Reilly É, Fitzgerald KC, Falcone GJ, Kolonel LN, Park Y, Gapstur SM, Ascherio A. Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies. Amyotrophic Lateral Sclerosis And Frontotemporal Degeneration 2015, 16: 366-371. PMID: 25822002, PMCID: PMC4589421, DOI: 10.3109/21678421.2015.1020813.Peer-Reviewed Original ResearchMeSH KeywordsAgedAmyotrophic Lateral SclerosisCaffeineCoffeeCohort StudiesFemaleHumansMaleMiddle AgedOdds RatioProportional Hazards ModelsRisk FactorsTeaConceptsAmyotrophic lateral sclerosisMultivariable-adjusted risk ratiosALS riskRisk ratioCohort studyLateral sclerosisCases of ALSCox proportional hazards regressionProportional hazards regressionLarge cohort studyIntake of caffeineAdenosine A2A receptorsRandom-effects modelConsumption of caffeineHazards regressionALS incidenceLowest quintileMotor neuronsCaffeine intakeA2A receptorsAssociation of caffeineLarger studyIntakeSclerosisRisk
2014
Dietary ω-3 Polyunsaturated Fatty Acid Intake and Risk for Amyotrophic Lateral Sclerosis
Fitzgerald KC, O’Reilly É, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A. Dietary ω-3 Polyunsaturated Fatty Acid Intake and Risk for Amyotrophic Lateral Sclerosis. JAMA Neurology 2014, 71: 1102-1110. PMID: 25023276, PMCID: PMC4160351, DOI: 10.1001/jamaneurol.2014.1214.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAmyotrophic Lateral SclerosisDietary SupplementsEnergy IntakeFatty Acids, Omega-3FemaleHumansLongitudinal StudiesMaleMiddle AgedProportional Hazards ModelsRiskConceptsAmyotrophic lateral sclerosisMultivariable-adjusted risk ratiosALS riskRisk ratioHealth StudyLateral sclerosisCancer Prevention Study II Nutrition CohortPolyunsaturated Fatty Acid IntakeCox proportional hazards regressionOnset of ALSHealth Professionals FollowHealth-AARP DietNurses' Health StudyFood frequency questionnaireFatty acid intakeSevere progressive diseaseProportional hazards regressionMultiethnic Cohort StudyRandom-effects methodDietary ωNutrition CohortProfessionals FollowCohort studyFrequency questionnaireProgressive diseaseDietary Fiber and Amyotrophic Lateral Sclerosis: Results From 5 Large Cohort Studies
Fondell E, O'Reilly É, Fitzgerald KC, Falcone GJ, Kolonel LN, Park Y, McCullough ML, Ascherio A. Dietary Fiber and Amyotrophic Lateral Sclerosis: Results From 5 Large Cohort Studies. American Journal Of Epidemiology 2014, 179: 1442-1449. PMID: 24816788, PMCID: PMC4051879, DOI: 10.1093/aje/kwu089.Peer-Reviewed Original ResearchMeSH KeywordsAgedAmyotrophic Lateral SclerosisCohort StudiesDietary FiberFemaleHumansMaleMiddle AgedProportional Hazards ModelsRiskConceptsAmyotrophic lateral sclerosisCohort studyALS riskFiber intakeLateral sclerosisCause of ALSLarge prospective cohort studyRisk of ALSProspective cohort studyHigh fiber intakeMedian survival timeCase-control studyLarge cohort studyProportional hazards modelCohort-specific estimatesRandom-effects modelInflammatory markersProspective studyHighest quintileALS casesDietary intakeCereal fiberSurvival timeLower riskHazards model
2013
Magnesium intake and risk of amyotrophic lateral sclerosis: Results from five large cohort studies
Fondell E, O’Reilly É, Fitzgerald KC, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A. Magnesium intake and risk of amyotrophic lateral sclerosis: Results from five large cohort studies. Amyotrophic Lateral Sclerosis And Frontotemporal Degeneration 2013, 14: 356-361. PMID: 23777266, PMCID: PMC3743429, DOI: 10.3109/21678421.2013.803577.Peer-Reviewed Original ResearchMeSH KeywordsAgedAmyotrophic Lateral SclerosisCohort StudiesDietFemaleHumansLongitudinal StudiesMagnesiumMaleMiddle AgedOdds RatioProportional Hazards ModelsProspective StudiesRisk FactorsConceptsAmyotrophic lateral sclerosisMagnesium intakeALS riskCohort studyLateral sclerosisCases of ALSLarge prospective cohort studyProspective cohort studyDietary magnesium intakeLow magnesium intakeCase-control studyLarge cohort studyProportional hazards modelCohort-specific estimatesRandom-effects modelProspective studyHighest quintileDietary intakeProtective effectHazards modelIntakeMagnesium absorptionSclerosisHeavy metal exposureRiskIntakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies
Fitzgerald KC, O'Reilly ÉJ, Fondell E, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A. Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies. Annals Of Neurology 2013, 73: 236-245. PMID: 23362045, PMCID: PMC3608702, DOI: 10.1002/ana.23820.Peer-Reviewed Original ResearchConceptsRisk of ALSAmyotrophic lateral sclerosisNurses' Health StudyRisk ratioALS deathsVitamin CLateral sclerosisHealth StudyCancer Prevention Study II Nutrition CohortCox proportional hazards regressionMultivariate risk ratiosRetired Persons DietHealth Professionals FollowVitamin C intakeNational Death IndexProportional hazards regressionHigh dietary intakeRandom-effects methodNutrition CohortProfessionals FollowCohort studyProspective cohortC intakeDeath IndexHazards regression
2012
Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: Results from five prospective cohort studies
Fondell E, O'Reilly ÉJ, Fitzgerald KC, Falcone GJ, McCullough ML, Thun MJ, Park Y, Kolonel LN, Ascherio A. Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: Results from five prospective cohort studies. Amyotrophic Lateral Sclerosis And Frontotemporal Degeneration 2012, 13: 573-579. PMID: 22871075, PMCID: PMC3474335, DOI: 10.3109/17482968.2012.703209.Peer-Reviewed Original ResearchConceptsNon-steroidal anti-inflammatory drugsProspective cohort studyNSAID useALS riskAnti-inflammatory drugsCohort studyNon-aspirin NSAID useNon-aspirin NSAID usersAmyotrophic lateral sclerosis (ALS) pathologyLarge prospective cohort studyProportional hazards modelAmyotrophic lateral sclerosisCohort-specific estimatesRandom-effects modelAspirin useNSAID usersProspective dataRelative riskPathological studiesLateral sclerosisHazards modelRiskEffects modelDrugsOverall effect